Ledger.Open graph →

SEC Form D · filed January 27, 2020

Lyra Therapeutics, Inc

Offering

$28.0M

Sold

$28.0M

Exemption

Rule 506(b)

Industry

Other

Location

WATERTOWN, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Michael Altman · Watertown, MADirector Maria Palasis, Ph.D · Watertown, MAExec · Director Edward Anderson · Watertown, MADirector Konstantin A. Poukalov · Watertown, MADirector Elisa Zhang · Bellevue, WADirector Jay Leek · West Palm Beach, FLDirector Lane Kawaoka · Aiea, HIExec · Director Anthony Deaugustine · Phoenix, AZDirector Ann Merrifield · Woburn, MADirector Bradford Smith · Watertown, MADirector George Whitesides · Waltham, MADirector Robert Langer · Bedford, MADirector Don Elsey · Watertown, MAExec Matthew E. Badler · SAINT LOUIS, MODirector Marc R. Hirshman · SAINT LOUIS, MOExec · Director Twain SNMTC LLC · Saint Louis, MODirector David Zeng · San Francisco, CADirector Ann Merrifield · Danvers, MADirector Bradford Smith · Watertown, MADirector George Whitesides · Cambridge, MADirector Robert Langer · PITTSBURGH, PADirector Don Elsey · Watertown, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗